Our analysis of available melanoma gene expression studies of melanoma tumors and patient-derived xenografts pre- and post-BRAFi (resistant) showed that several DUSPs, including DUSP1, are downregulated in the resistant tumors (both in bulk and single cell RNAseq datasets). This evidence concerns the gene DUSP1 and melanoma.